Dow Jones Top Markets Headlines at 7 PM ET: Investors' Optimism for Lower Rates Lifts Nasdaq to Another Record | Fitch ... Both the Nasdaq and S&P 500 posted weekly gains of more than 1% ahead of the ...

Dow Jones Top Company Headlines at 7 PM ET: Winklevoss-Backed Gemini Soars in Latest IPO Market Win | Bank ... The crypto exchange rises 14% in its Nasdaq debut, the resurgent IPO market's latest ...

The note will be due and payable 12 months after the issue date.

NextEra Energy's high-quality regulated utility in Florida and fast-growing renewable energy business give investors the best of both worlds: a secure dividend and industry-leading renewable energy ...

With 15.18 million shares being offered for sale - fewer than the expected 16.67 million - Gemini's IPO raised about $425 ...

The IPO raised $492.86 million, with $164.29 million going to the company and $328.57 million to selling shareholders. The lead underwriters were Goldman Sachs, Morgan Stanley, Allen & Co. and Wells ...

U.S. inflation, as measured by the consumer-price index, rose 0.4% in August at an annual rate of 2.9%. Core inflation, which excludes food and energy prices, was up 3.1% in the 12 months through ...

Shares of power producers rose, as traders rotated into the defensive sector ahead of the Federal Reserve meeting. Treasury yields continued their retreat ahead of the central-bank meeting, making the ...

Shares of banks and other financial institutions added to gains on Federal Reserve rate-cut bets. Gemini Space Station soared on their stock-market debut, netting billions of dollars in paper profits ...

Shares of industrial and transportation companies fell amid nerves ahead of the Federal Reserve's meeting. Shares of Joby and Archer Aviation jumped after the companies said they would participate in ...

Adobe shares fell after the maker of design software's fiscal third-quarter earnings trailed some investors' expectations. Adobe's growth drivers are shifting to "AI-first" products, said strategists ...

Alkermes filed a patent infringement lawsuit against Teva Pharmaceuticals, Apotex and MSN Pharmaceuticals for trying to make generic versions of its schizophrenia and bipolar treatment Lybalvi.